Werkgroep Cardiologische centra Nederland

DECLARE TIMI 58 (Completed)

Multicenter Trial to Evaluate the Effect of Dapagliflozin on the Incidence of Cardiovascular Events (DECLARE-TIMI58)
Medicine
dapagliflozin
Population
Diabetes mellitus
Phase
III
Starting year
2013
More information
ClinicalTrials.gov

Director of Study

dr. A.J.M. Oude Ophuis (Cardioloog)
Nijmegen, Canisius-Wilhelmina Ziekenhuis